P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID?

by Felipe Ramírez, Alvaro Urzúa, Máximo Cattaneo, Pablo Roblero Juan, Jaime Poniachik
Published 2021-09-01

P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE

by Gabriel Uribe, Alvaro Urzua, Maximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION

by Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS

by Aline Lamaison, Javier Troncoso, Pablo Villafranca, Marcel Bonilla, Maximo Cattaneo, Laura Carreño, Jaime Poniachik, Alvaro Urzúa
Published 2021-09-01

P-61 LIVER TRANSPLANTATION IN HEPATOCARCINOMA: SURVIVAL AND RECURRENCE IN TRANSPLANTED PATIENTS WITH HEPATOCARCINOMA

by Daniela García, Fodda Chelech, Andrea Jiménez, Alvaro Urzúa, Maximo Cattaneo, Juan Pablo Roblero, Alexis Iracheta, Jaime Poniachik
Published 2021-09-01

P-38 UTILITY OF PUPILLARY REACTIVITY IN THE FUNCTIONAL ASSESSMENT OF THE AUTONOMOUS NERVOUS SYSTEM IN PATIENTS WITH CHRONIC LIVER DISEASE: PRELIMINARY RESULTS

by Christian Lara, Abraham Gajardo, Flavia Giubergia, Nicolás Bustos, Juan Pablo Roblero, Alvaro Urzúa, Jaime Poniachik, Máximo Cattaneo
Published 2021-09-01

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

by Juan Francisco Rozas, Katherine González, Camila Estay, Maximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Alexandra Sandoval, Jaime Poniachik
Published 2021-09-01

P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS

by Juan Francisco Rozas, Katherine González, Camila Estay, Maximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Alexandra Sandoval, Jaime Poniachik
Published 2021-09-01

P-67 ULTRASOUND GUIDED TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS AND STAGING OF LIVER FIBROSIS

by Juan Francisco Rozas, Katherine González, Luis Salazar, Máximo Cattaneo, Juan Pablo Roblero, Alvaro Urzúa, Alexandra Sandoval, Jaime Poniachik
Published 2021-09-01

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION

by Andrea Jiménez, Alan Poniachik, Eladio González, Andrés De la Vega, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik, Alvaro Urzúa
Published 2021-09-01

P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY

by Claudia Muñoz, Felipe Ramírez, Nicolás Martínez, Patricio Palavecino, Claudia Pavez, Alvaro Urzúa, Máximo Cattaneo, Juan Pablo Roblero, Jaime Poníachik
Published 2021-09-01

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA

by Alejandra Domínguez, Gabriel Puelma, Marcelo Salinas, Máximo Cattaneo, Javier Ortiz, Patricio Palavecino, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE

by Hiru Chang, Danett Guiñez, Juan Francisco Rozas, Fodda Chelech, Víctor Henríquez, Alvaro Urzúa, Maximo Cattaneo, Juan Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-64 THE ALCOHOL-ASSOCIATED LIVER DISEASE PARADOX IN CHILE: AN ASSESSMENT WITH DATA FROM THE NATIONAL HEALTH SURVEY (ENS 2016-2017)

by Gianfranco Oneto, Luis Antonio Díaz, Francisco Idalsoaga, Juan Pablo Arab, Pablo Roblero, Maximo Cattaneo, Alvaro Urzua, Jaime Poniachik, Juan Pablo Roblero
Published 2021-09-01

P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER

by Ana Jiménez, Felipe Contreras, Miguel Leiva José, Nicolás Moreno, Claudio Altschiller, Andrea Jimenez, Alvaro Urzúa, Maximo Cattaneo, Laura Carreño, Juan Pablo Roblero, Jaime Poniachik
Published 2021-09-01

P-13 COMPARISON OFF DIFFERENT PROGNOSTIC SCORES FOR PATIENTS WITH CIRRHOSIS HOSPITALIZED WITH SARS – COV 2 INFECTION

by Manuel Mendizabal, Ezequiel Ridruejo, Federico Piñero, Margarita Anders, Martín Padilla, Luis G. Toro, Aldo Torre, Pedro Montes, Alvaro Urzúa, Esteban Gonzalez Ballerga, María Dolores Silveyra, Douglas Michelato, Javier Díaz, Mirta Peralta, Josefina Pages, Sandro Ruiz García, Isabel Gutierrez Lozano, Yuridia Macias, Daniel Cocozzella, Norberto Chavez-Tapia, Martín Tagle, Alejandra Dominguez, Adriana Varón, Emilia Vera Pozo, Fátima Higuera-de la Tijera, Carla Bustios, Damiá Conte, Nataly Escajadillo, Andrés J Gómez, Laura Tenorio, Mauricio Castillo Barradas, Maria Isabel Schinoni, Fernando Bessone, Fernando Contreras, Leyla Nazal, Abel Sanchez, Matías García, Julia Brutti, María Cecilia Cabrera, Godolfino Miranda-Zazueta, German Rojas, Maximo Cattaneo, Graciela Castro-Narro, Fernando Rubinstein, Marcelo O. Silva
Published 2021-09-01